$CBDD "We are very pleased to report strong year-over-year revenue growth in the first nine months of 2021, and importantly, year-to-date, we have already surpassed our 2021 revenue guidance of $22 million (USD)," commented Marcel Gamma, CEO. "The Company remains focused on continued growth while simultaneously moving forward on the completion of its GAAP audit required to become a fully reporting issuer with the SEC, which will enable the Company to move beyond the OTC Pink Market where it can provide investors with improved transparency and increased liquidity."
(0)
(0)